News & Information
At Memorial Sloan Kettering, our leading edge research is constantly advancing what we know about cancer and new discoveries are improving care for patients here, and all over the world. In News and Information, you will find information about our groundbreaking work and the dedicated professionals who make it all happen.
For Journalists
Connect with us to reach MSK experts for media inquiries and for story ideas.
MSK received top rankings in gynecology, urology, and several subspecialties
President Biden announced on September 15 his appointment of MSK medical oncologist and Head of the Division of Solid Tumor Oncology, Luis Alberto Diaz, Jr., MD, as one of seven distinguished members of the National Cancer Advisory Board.
In the News
Learn why Black women face a higher risk of death from endometrial cancer, and about a new effort led by Dr. Carol Brown at Memorial Sloan Kettering Cancer Center to close the gap.
Former college lacrosse player Mikaela Rix, diagnosed at age 26, accessed a wide range of resources offered by MSK’s new program tailored for young women with breast cancer.
Learn why Bobby Logan chose active surveillance for his prostate cancer, and how he was successfully treated after his tumor changed.
Stay Connected with MSK
News Releases
Deb Schrag, MD, MPH, has been named the new Chair of the Department of Medicine at Memorial Sloan Kettering Cancer Center (MSK).
Louis V. Gerstner, Jr. makes a generous $25 million commitment to establish the Louis V. Gerstner, Jr. Physician Scholars Program.
The Lisa and Scott Stuart Center for Adolescent and Young Adult Cancers will revolutionize cancer treatment for people ages 15 to 39.
Media Coverage
MSK’s Neil Iyengar and a patient are featured on the relationship between diet, metabolism and cancer.
Wednesday, October 20, 2021
MSK’s Elizabeth Comen discusses the latest advances in breast cancer, prevention, and treatment with Good Morning America.
Monday, October 18, 2021
MSK’s Mary Gemignani and patient Mikaela Rix discuss Mikaela’s breast cancer journey and treatment at MSK, and talk about the importance of tailored treatments for younger women with breast cancer.
Friday, October 15, 2021
News from the Lab
Part natural killer, part T cell, this hybrid immune cell has a “double sword” for fighting cancer.
Could an implantable IUD help detect cancer early, when it is most curable? Scientists at the Sloan Kettering Institute are betting yes.
Meet Zhongmin Wang, a fifth-year doctoral student in the Gerstner Sloan Kettering Graduate School of Biomedical Sciences (GSK), who has been awarded the 2021 Chairman’s Prize.
MSK News
MSK is helping young patients navigate their journey and get the best treatment through specialized counseling, digital connections, and more. “The gratitude I feel is so deep. I’m not just alive; I’m living,” says Desiree Allen.
MSK doctors, such as Julia Glade Bender, are achieving better outcomes for patients by personalizing treatment on the basis of the biology of the cancer rather than the patient’s age.
Meet the Stuart family and learn why they want to revolutionize cancer treatment for people ages 15 to 39 and meet their very specific and often unmet needs.
2020 Annual Report: Meeting the Moment
MSK researchers like physician-scientist Karuna Ganesh are using an innovative technology called organoids to unlock the mysteries of cancer metastasis.
In her new role as Chief Health Equity Officer, gynecologic cancer surgeon Carol Brown is leading a new commitment to reducing cancer disparities. Dr. Brown spoke with NBC’s Today show anchor Al Roker about raising awareness about these disparities.
Memorial Sloan Kettering staff, patients, and donors stepped up in extraordinary ways during the COVID-19 pandemic. Meet just some of these heroes.